Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Explore the question of which is better for daily expenses: cash back or points. Make informed choices to maximize your rewards potential.
27,346 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Oil prices jumped after renewed fighting between the U.S. and Iran, delivering the prices largest two-day percentage ...
Tesla stock has slid about 18% from its December peak as deliveries declined and autonomy safety metrics raise questi...
Investors are watching IonQ as it edges toward scalable quantum systems through a photonic interconnect. This breakth...
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
SMCI and Gorilla Technology stock fell sharply after a $2 billion India AI infrastructure deal. Investors are weighin...
Investors watch for another Fed rate cut as IEFA shows resilience. This article outlines key data and signals to moni...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...
Markets lean on Treasurys as the only credible anchor amid volatility. Analysts say the U.S. debt market remains the ...
As Stanford’s AI Index shows lagging adoption in the U.S., analysts say the real payoff comes from integration and tr...
OpenAI is moving toward a potential trillion-dollar IPO, with confidential SEC filings reportedly underway and a Sept...
AI is shifting from basic automation to decision-support tools in personal finance. This report explores where AI act...